Skip to search formSkip to main contentSkip to account menu

NVP-LAF237

Known as: NVP-LAF-237 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Triple-drug infant antiretroviral prophylaxis containing nevirapine (NVP) is increasingly used to prevent HIV… 
2018
2018
The pathophysiology of body weight gain that is observed in patients suffering from myeloproliferative neoplasms treated with… 
2016
2016
Background: Tenofovir and nevirapine are associated with kidney and liver toxicity respectively; hence concurrent use might be… 
2015
2015
In drug development and clinical trials attention is paid not only to pharmacokinetic analysis of the drug, but also to tumor… 
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Neuroblastoma is the most common cancer in infancy… 
2009
2009
Glucagon-like peptide-1 (GLP-1) analogues and inhibitors of its degrading enzyme, dipeptidyl peptidase IV (DPPIV), are… 
2006
2006
Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a new type of antidiabetic drugs. Most known DPP-IV inhibitors… 
1990
1990
Abstract : This study identified the hypermetabolic and thermoregulatory effects of burn wound colonization and examined the role…